arrow
E

Evelien Kuip

radboud medical center
H指数:15
被引数:705

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Symptom burden profiles and applied medication strategies in the days before and after initiation of palliative sedation in advanced cancer patients: an international prospective multicentre observational study (PALSED)

晚期癌症患者姑息镇静开始前后症状负担特征及用药策略:一项国际前瞻性多中心观察性研究(PALSED)

2026-10-270
OAAI
Clinical decision-making on palliative sedation in European palliative care settings: a prospective multicentre observational study (PALSED)

欧洲姑息治疗环境下姑息镇静的临床决策:一项前瞻性多中心观察性研究(PALSED)

2026-09-250
OA
Timely Integration of specialist palliative care into oncology care for patients receiving radiotherapy for bone metastases: A study procotol for the TIPZO-RT Randomized Controlled Trial

骨转移患者放疗期间及时整合专科姑息护理入肿瘤护理:TIPZO-RT随机对照试验研究方案

2026-05-010
PRE
Circulating Tumor Cells Enhance Prognostic Stratification Beyond ER Assessment by Biopsy or FES-PET in Endocrine-Treated Metastatic Breast Cancer

循环肿瘤细胞通过活检或FES-PET评估之外增强内分泌治疗转移性乳腺癌的预后分层

2026-04-170
OA
Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer

FES-PET/CT与FDG-PET/CT在ER阳性转移性浸润性小叶乳腺癌患者中的比较分析

2025-09-130
PREAI
Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative,-Low, and-Positive Metastatic Breast Cancer

在HER2-Negative,低和阳性转移性乳腺癌中通过HER2 PET鉴定的全身HER2异质性

2024-09-052
PRE
Intensified alkylating chemotherapy with autologous stem cell rescue (IACT) or conventional chemotherapy followed by olaparib (CCT-O) in stage III, HER2-negative, homologous recombination deficient (HRD) breast cancer (BC): Survival results of the randomized-controlled SUBITO trial

高强度烷化剂化疗联合自体干细胞救援(IACT)或常规化疗后序贯奥拉帕利(CCT-O)治疗III期、HER2阴性、同源重组缺陷(HRD)乳腺癌(BC):随机对照SUBITO试验的生存结果

2024-09-010
PRE
Correlation between Histopathological Prognostic Tumor Characteristics and [18F]FDG Uptake in Corresponding Metastases in Newly Diagnosed Metastatic Breast Cancer
2024-02-142
OAAI
Trajectories of health-related quality of life and symptom burden in patients with advanced cancer towards the end of life: Longitudinal results from the eQuiPe study

生命末期晚期癌症患者与健康相关的生活质量和症状负担的轨迹: eQuiPe研究的纵向结果

CANCER
IF5.1
2023-10-1313
PRE